Patent details

Basic Information

Publication number:

EP2020236

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP081685653

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

French

English Title of Invention:

Method of contraception based on a progestative and oestrogen

French Title of Invention:

Méthode contraceptive à base d'un progestatif et d'un estrogéne

German Title of Invention:

Verfahren zur Empfängnisverhütung auf der Basis eines Progestativs und eines Oestrogens

SPC Number:

Dates

Filing date:

24/10/2000

Grant date:

27/01/2016

EP Publication Date:

27/01/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/02/2009

EP B1 Publication Date:

27/01/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/10/2016

Expiration date:

24/10/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/02/2016

 

 

Name:

Teva Pharmaceuticals International GmbH

Address:

Schlüsselstrasse 12, 8645 Jona, Switzerland (CH)

Inventor

1

Name:

Paris Jacques

Address:

France (FR)

2

Name:

Thomas Jean-Louis

Address:

France (FR)

Priority

Priority Number:

02587

Priority Date:

25/10/1999

Priority Country:

France (FR)

Classification

Main IPC Class:

A61K 31/57;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages